These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 35278438
1. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma. Cid-Bertomeu P, Huerva V. Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438 [Abstract] [Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H, McCormick SA, Finger PT. Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [Abstract] [Full Text] [Related]
3. Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions. Nuessle S, Auw-Haedrich C, Jiang J, Boehringer D, Reinhard T. Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1159-1166. PubMed ID: 36255550 [Abstract] [Full Text] [Related]
10. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman. Colby KA, Nagel DS. Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614 [Abstract] [Full Text] [Related]
11. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Finger PT, Czechonska G, Liarikos S. Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051 [Abstract] [Full Text] [Related]